The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
2011

The Role of Noggin in Prostate Cancer Bone Metastasis

Sample size: 14 publication 10 minutes Evidence: high

Author Information

Author(s): Chiara Secondini, Antoinette Wetterwald, Ruth Schwaninger, George N. Cecchini, Marco G.

Primary Institution: University of Bern, Bern, Switzerland

Hypothesis

Cancer cell-derived noggin may contribute to the pathogenesis of osteolytic bone metastasis of solid cancers by repressing bone formation.

Conclusion

Suppressing noggin in prostate cancer cells can restore bone formation and limit tumor growth in bone metastases.

Supporting Evidence

  • Silencing noggin in prostate cancer cells preserved bone formation in osteolytic lesions.
  • Noggin suppression limited tumor growth in bone.
  • Xenografts with noggin-silenced cells showed increased bone density.
  • Histomorphometric analysis indicated normalization of osteoblast activity.

Takeaway

This study shows that a protein called noggin, made by cancer cells, stops bones from healing when cancer spreads there, but if we turn off noggin, the bones can start to heal again.

Methodology

The study used intra-osseous xenografts of PC-3 prostate cancer cells in mice to analyze the effects of noggin suppression on bone formation and tumor growth.

Potential Biases

Potential bias in the interpretation of results due to the use of a single animal model.

Limitations

The study primarily focused on a single cancer cell line and may not represent all prostate cancer behaviors.

Participant Demographics

Mice were used for the experiments, specifically BALB/c nude mice aged 7-8 weeks.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0016078

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication